Book contents
- How to Prepare the Egg and Embryo to Maximize IVF Success
- How to Prepare the Egg and Embryo to Maximize IVF Success
- Copyright page
- Contents
- Contributors
- Section 1 Oocyte Recruitment
- Section 2 Stimulation for IVF
- Section 3 Supplements to Improve Oocytes
- Chapter 11 The Use of DHEA to Improve Oocyte Quality
- Chapter 12 Implications of Polycystic Ovary Syndrome on Oocyte Quality
- Chapter 13 The Use of Melatonin to Improve Oocyte Development
- Chapter 14 The Use of LH Supplements to Improve the Response to Ovarian Stimulation
- Chapter 15 Growth Hormone as an Adjunct to Controlled Ovarian Hyperstimulation for IVF
- Chapter 16 Mitochondrial Transfer Technology for Improving Older Eggs
- Section 4 Oocyte and Embryo Culture
- Section 5 Embryo Selection and Transfer
- Index
- References
Chapter 12 - Implications of Polycystic Ovary Syndrome on Oocyte Quality
from Section 3 - Supplements to Improve Oocytes
Published online by Cambridge University Press: 04 January 2019
Book contents
- How to Prepare the Egg and Embryo to Maximize IVF Success
- How to Prepare the Egg and Embryo to Maximize IVF Success
- Copyright page
- Contents
- Contributors
- Section 1 Oocyte Recruitment
- Section 2 Stimulation for IVF
- Section 3 Supplements to Improve Oocytes
- Chapter 11 The Use of DHEA to Improve Oocyte Quality
- Chapter 12 Implications of Polycystic Ovary Syndrome on Oocyte Quality
- Chapter 13 The Use of Melatonin to Improve Oocyte Development
- Chapter 14 The Use of LH Supplements to Improve the Response to Ovarian Stimulation
- Chapter 15 Growth Hormone as an Adjunct to Controlled Ovarian Hyperstimulation for IVF
- Chapter 16 Mitochondrial Transfer Technology for Improving Older Eggs
- Section 4 Oocyte and Embryo Culture
- Section 5 Embryo Selection and Transfer
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- How to Prepare the Egg and Embryo to Maximize IVF Success , pp. 150 - 154Publisher: Cambridge University PressPrint publication year: 2019
References
Dumesic, D.A., Oberfield, S.E., Stener-Victorin, E. et al., Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 2015, 36(5): pp. 487–525.Google Scholar
Qiao, J. and Feng, H.L., Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum Reprod Update 2011, 17(1): pp. 17–33.CrossRefGoogle ScholarPubMed
Webber, L.J., Stubbs, S., Stark, J. et al., Formation and early development of follicles in the polycystic ovary. Lancet 2003, 362(9389): pp. 1017–21.CrossRefGoogle ScholarPubMed
Homburg, R. and Crawford, G., The role of AMH in anovulation associated with PCOS: a hypothesis. Hum Reprod 2014, 29(6): pp. 1117–21.Google Scholar
Stubbs, S.A., Stark, J., Dilworth, S.M., Franks, S., and Hardy, K., Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division. J Clin Endocrinol Metab 2007, 92(11): pp. 4418–26.CrossRefGoogle ScholarPubMed
Dewailly, D., Robin, G., Peigne, M. et al., Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update 2016, 22(6): pp. 709–24.CrossRefGoogle ScholarPubMed
Li, H.W., Lee, V.C., Lau, E.Y. et al., Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment. J Assist Reprod Genet 2014, 31(2): pp. 205–11.Google Scholar
Eppig, , John, J., Carrie, M.M.V.Bivens, Marin, and de La Fuente, Rabindranath, Regulation of Mammalian Oocyte Maturation, in Peter, E.Y.A. and Leung, C.D. (eds.) The Ovary. 2004 Elsevier Academic Press, Oxford UK. pp. 118–23.Google Scholar
Sigala, J., Sifer, C., Dewailly, D. et al., Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection? Results from a prospective, comparative study. Fertil Steril 2015, 103(1): pp. 112–18.Google Scholar
Esinler, I., Bayar, U., Bozdag, G., and Yarali, H., Outcome of intracytoplasmic sperm injection in patients with polycystic ovary syndrome or isolated polycystic ovaries. Fertil Steril 2005, 84(4): pp. 932–7.CrossRefGoogle ScholarPubMed
Heijnen, E.M., Eijkemans, M.J., Hughes, E.G. et al., A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 2006, 12(1): pp. 13–21.Google Scholar
Weghofer, A., Munne, S., Chen, S., Barad, D., and Gleicher, N., Lack of association between polycystic ovary syndrome and embryonic aneuploidy. Fertil Steril 2007, 88(4): pp. 900–5.Google Scholar
Wood, J.R., Dumesic, D.A., Abbott, D.H., and Strauss, J.F., 3rd, Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab 2007, 92(2): pp. 705–13.Google Scholar
Huang, X., Hao, C., Shen, X. et al., Differences in the transcriptional profiles of human cumulus cells isolated from MI and MII oocytes of patients with polycystic ovary syndrome. Reproduction 2013, 145(6): pp. 597–608.Google Scholar
Liu, S., Zhang, X., Shi, C. et al., Altered microRNAs expression profiling in cumulus cells from patients with polycystic ovary syndrome. J Transl Med 2015, 13: p. 238.Google Scholar
Tesarik, J. and Mendoza, C., Direct non-genomic effects of follicular steroids on maturing human oocytes: oestrogen versus androgen antagonism. Hum Reprod Update 1997, 3(2): pp. 95–100.CrossRefGoogle ScholarPubMed
Vassiliadi, D.A., Barber, T.M., Hughes, B.A. et al., Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009, 94(9): pp. 3558–66.Google Scholar
Marquard, K.L., Stephens, S.M., Jungheim, E.S. et al., Polycystic ovary syndrome and maternal obesity affect oocyte size in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertil Steril 2011, 95(6): pp. 2146–9, 2149 e1.Google Scholar
Cano, F., Garcia-Velasco, J.A., Millet, A. et al., Oocyte quality in polycystic ovaries revisited: identification of a particular subgroup of women. J Assist Reprod Genet 1997, 14(5): pp. 254–61.Google Scholar
Niu, Z., Lin, N., Gu, R., Sun, Y., and Feng, Y., Associations between insulin resistance, free fatty acids, and oocyte quality in polycystic ovary syndrome during in vitro fertilization. J Clin Endocrinol Metab 2014, 99(11): pp. E2269–76.Google Scholar
Merhi, Z., Advanced glycation end products and their relevance in female reproduction. Hum Reprod 2014, 29(1): pp. 135–45.Google Scholar
Kalra, S.K., Ratcliffe, S.J., and Dokras, A., Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate. Fertil Steril 2013, 100(1): pp. 208–13.Google Scholar
Ramezanali, F., Ashrafi, M., Hemat, M. et al., Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Mullerian hormone. Reprod Biomed Online 2016, 32(5): pp. 503–12.Google Scholar
Sahu, B., Ozturk, O., Ranierri, M., and Serhal, P., Comparison of oocyte quality and intracytoplasmic sperm injection outcome in women with isolated polycystic ovaries or polycystic ovarian syndrome. Arch Gynecol Obstet 2008, 277(3): pp. 239–44.Google Scholar
Siristatidis, C., Sergentanis, T.N., Vogiatzi, P. et al., In vitro maturation in women with vs. without polycystic ovarian syndrome: A systematic review and meta-analysis. PLoS One 2015, 10(8): p. e0134696.CrossRefGoogle ScholarPubMed